About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Nashville | 763 Studies

Clinical Trials Breast CancerNashville

Breast Cancer Clinical Trials in Nashville

Find 763 clinical trials for breast cancer near Nashville, Tennessee. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Nashville

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 521-540 of 763 trials

CompletedA Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795This study is a first time in human, Phase I, open-label, dose-escalation study of the oral AKT inhibitor GSK2141795 in subjects with solid tumors or lymphomas.NCT00920257·Baltimore, Maryland and 6 others CompletedQuality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerThis research trial studies quality of life, employment, and informal care cost analysis in patients with breast cancer receiving chemotherapy.NCT00115505·Mobile, Alabama and 226 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast CancerThis dose finding/extension study was designed originally to consist of three parts: Part A was intended to identify the MTD of the AZD2014/ palbociclib combination on a…NCT02599714·Encinitas, California and 6 others

CompletedA Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast CancerThis is a global Phase III, double-blind, randomized, placebo-controlled study designed to evaluate the efficacy and safety of neoadjuvant treatment with atezolizumab…NCT03197935·Palo Alto, California and 67 others

RecruitingA Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast CancerThis is a first in human dose escalation and expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) activity, and preliminary anti-tumor…NCT05187832·Nashville, Tennessee

Active not recruitingExtension Study of Lapatinib Plus Herceptin With or Without Endocrine TherapyBreast cancer is the most common malignancy in the U.S. Targeted therapies such as tamoxifen have been revolutionary in reducing tumor recurrences and mortality in early breast…NCT00999804·Birmingham, Alabama and 7 others

Active not recruitingT-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCAThis research study is studying a combination of drugs as a possible treatment for breast cancer that has tested positive for a protein called HER2.NCT02326974·Boston, Massachusetts and 3 others

CompletedLEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or…NCT02187783·Birmingham, Alabama and 60 others

RecruitingA Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatment of HR-positive…NCT07062965·Anchorage, Alaska and 432 others

RecruitingA Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerThis is an umbrella study evaluating the efficacy and safety of multiple treatment combinations in participants with metastatic or inoperable locally advanced breast cancer.NCT03424005·Duarte, California and 54 others

RecruitingStudy of XB010 in Subjects With Solid TumorsThis is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with…NCT06545331·Irvine, California and 19 others

RecruitingA Study of PHST001 in Advanced Solid TumorsThis is a multi-center, first-in-human (FIH), open-label, Phase 1a/1b dose escalation and dose expansion study to assess the safety, PK, pharmacodynamics, and antitumor activity…NCT06840886·Beverly Hills, California and 19 others

TerminatedStudy of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast CancerThis is a multicenter, Phase 1b-2 study of elacestrant in combination with onapristone in patients with advanced/metastatic ER+/PgR+/HER2- breast cancer.NCT05618613·Phoenix, Arizona and 2 others

RecruitingStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsThis Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx)…NCT06545942·Goodyear, Arizona and 17 others

CompletedA Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast CancerThis was an open-label, multicenter, dose-escalation study designed to assess the safety, tolerability, and PK of IV administered DAN-222 followed by a dose-escalation of DAN-222…NCT05261269·La Jolla, California and 8 others

TerminatedPivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast CancerThis is a phase 3, multicenter, open-label, randomized active-controlled, parallel group to investigate the efficacy, safety and tolerability of intravenous balixafortide given…NCT03786094·Fresno, California and 87 others

CompletedPhase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase InhibitorThis study was a multi-center, randomized, double-blind, placebo controlled Phase III study to determine the efficacy and safety of treatment with buparlisib plus fulvestrant…NCT01610284·Mobile, Alabama and 267 others

CompletedA Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast CancerThis study will evaluate the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple-negative…NCT03371017·Fort Myers, Florida and 123 others

CompletedIrinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineThe purpose of this phase II, randomized, open-label clinical trial is to study 2 schedules of single-agent Irinotecan in women with metastatic breast cancer who have experienced…NCT00072852·Mobile, Alabama and 65 others

RecruitingTReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXdThe purpose of this study is to test the safety and effectiveness of the sequence of two investigational drugs (trastuzumab deruxtecan followed by datopotamab deruxtecan, or…NCT06533826·Birmingham, Alabama and 10 others

PreviousPage 27 of 39Next

Other Conditions in Nashville

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma